Xencor, Inc.
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38
Last updated:
Abstract:
The present invention is directed to heterodimeric antibodies that bind CD3 and CD38.
Status:
Application
Type:
Utility
Filling date:
22 Oct 2019
Issue date:
25 Jun 2020